Results 81 to 90 of about 33,501 (182)

A study of physiological mechanisms and inter-relations between systemic and regional blood volume, blood flow and electrolyte balance Interim progress report, Jun. 30 - Dec. 31, 1967 [PDF]

Regulation of sodium excretion in dog, and effects of atrial size and function upon secretion of sodium load - circulatory response to upright ...
Abelmann, W. H., Earley, L. E.
core   +2 more sources

Right atrial volume index and right atrial volume predict atrial fibrillation recurrence: A meta-analysis.

PLoS ONE
BackgroundAtrial volume index and atrial volume have recently been identified as predictors of atrial fibrillation (AF) recurrence following electrical cardioversion or radiofrequency ablation. However, most studies have reported the relationship between
Jia-Ming Han, Qian Xie, Xiu-Ying Song, Yu-Lan Ma   +3 more
doaj   +1 more source

Lost in translation? Theory, policy and practice in systems-based environmental approaches to obesity prevention in the Healthy Towns programme in England.

, 2014
This paper explores how system-wide approaches to obesity prevention were 'theorised' and translated into practice in the 'Healthy Towns' programme implemented in nine areas in England.
Cummins, Steven, Goodwin, Denise, Jones, Andy, Ogilvie, David, Petticrew, Mark, Sautkina, Elena, White, Martin   +6 more
core   +1 more source

Cardioversion [PDF]

Emergency Medicine Australasia, 2014
openaire   +2 more sources

Cardioversion

Cardioversion (CV) is a procedure consisting of 2 different applications, electrical or medical, performed to provide normal sinus rhythm in arrhythmic events. Electrical cardioversion is the preferred direct current-mediated treatment for arrhythmia without sinus rhythm when there is no response to pharmacological therapy or hemodynamic instability ...
openaire   +2 more sources

Current Status of Internal Cardioversion in Atrial Fibrillation.

Indian Pacing and Electrophysiology Journal, 2002
For more than 30 years transthoracic external cardioversion has been an established method for the restoration of sinus rhythm in patients with persistent atrial fibrillation. It was first described by Lown in 19631.
Andreas Plewan, Eckhard Alt
doaj  

Baseline NT-Pro-BNP Levels and Arrhythmia Recurrence in Outpatients Undergoing Elective Cardioversion of Persistent Atrial Fibrillation: A Survival Analysis

Indian Pacing and Electrophysiology Journal, 2009
Background: Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Elective electrical cardioversion is often performed in patients with persistent AF to attempt sinus rhythm (SR) restoration. However, AF recurrences are
Tommaso Sanna, Andrea Sonaglion, Maurizio Pieroni, Antonio Dello Russo, Gemma Pelargonio, Michela Casella, Evelina Zichichi, Giuseppe La Torre, Maria Lucia Narducci, Fulvio Bellocci   +9 more
doaj  

Aggressive Rhythm Control Strategy in Atrial Fibrillation Patients Presenting at the Emergency Department: The HEROMEDICUS Study Design and Initial Results

Journal of Cardiovascular Development and Disease
Atrial fibrillation has progressively become a more common reason for emergency department visits, representing 0.5% of presenting reasons. Registry data have indicated that about 60% of atrial fibrillation patients who present to the emergency ...
Dimitrios Tsiachris, Nikos Argyriou, Panagiotis Tsioufis, Christos Konstantinos Antoniou, Aggeliki Laina, George Oikonomou, Ioannis Doundoulakis, Athanasios Kordalis, Kyriakos Dimitriadis, Konstantinos Gatzoulis, Konstantinos Tsioufis   +10 more
doaj   +1 more source

Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? [PDF]

, 2014
Al-Khatib, SM, Banerjee, A, Blendea, D, Camm, AJ, Conroy, JM, Cosio, FG, De Bono, J, G Cosio, MD, Guasch, E, Halperin, JL, Hess, PL, Kirchhof, P, Lip, GY, Nattel, S, Ruskin, J, Savelieva, I   +15 more
core   +1 more source

Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study

Российский кардиологический журнал, 2005
In a placebo-controlled study, propafenone efficacy and safety for pharmaceutical cardioversion in atrial fibrillation (AF) paroxysms were studied. The study included 50 patients aged 28-69 years (mean age 53,9+9,7), with AF paroxysms lasting for less ...
Yu. A. Bunin, L. K. Anfalova
doaj